Oculus Innovative Sciences Inc (OCLS) - Financial Analysis Review

Summary

Oculus Innovative Sciences Inc (Oculus) is a specialty pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, womens healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare. Oculus develops its products based on shelf-stable microcyn technology platform. It sells its products through OTC stores.

GlobalData's Oculus Innovative Sciences Inc (OCLS) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Oculus Innovative Sciences Inc Key Recent Developments:

Nov 10,2016: Oculus Innovative Sciences Reports Financial Results for Fiscal Second Quarter 2017
Aug 11,2016: Oculus Innovative Sciences Receives Australian Approvals to Market Sterile Microcyn-Based Antimicrobial Solutions and Hydrogel Dressings
Jul 28,2016: Oculus Innovative Sciences Reports Financial Results for First Quarter of Fiscal Year 2017
Jul 06,2016: Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data
Jun 16,2016: Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth,